FDA Approved Products
| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|
| 215239 | NDA | CATALYST PHARMS | | 001 | AGAMREE | SUSPENSION;ORAL | 40MG/ML | VAMOROLONE | 2023-10-26 | Prescription | Yes |
| 208078 | NDA | CATALYST PHARMS | | 001 | FIRDAPSE | TABLET;ORAL | EQ 10MG BASE | AMIFAMPRIDINE PHOSPHATE | 2018-11-28 | Prescription | Yes |
| 208277 | NDA | CATALYST PHARMS | | 001 | FYCOMPA | SUSPENSION;ORAL | 0.5MG/ML | PERAMPANEL | 2016-04-29 | Prescription | Yes |
| 202834 | NDA | CATALYST PHARMS | | 001 | FYCOMPA | TABLET;ORAL | 2MG | PERAMPANEL | 2012-10-22 | Prescription | No |
| 002 | FYCOMPA | TABLET;ORAL | 4MG | PERAMPANEL | 2012-10-22 | Prescription | No |
| 003 | FYCOMPA | TABLET;ORAL | 6MG | PERAMPANEL | 2012-10-22 | Prescription | No |
| 004 | FYCOMPA | TABLET;ORAL | 8MG | PERAMPANEL | 2012-10-22 | Prescription | No |
| 005 | FYCOMPA | TABLET;ORAL | 10MG | PERAMPANEL | 2012-10-22 | Prescription | No |
| 006 | FYCOMPA | TABLET;ORAL | 12MG | PERAMPANEL | 2012-10-22 | Prescription | Yes |